Todorović S. RISK OF COVID-19 INFECTION IN PATIENTS WITH MULTIPLE SCLEROSIS TREATED WITH OCRELIZUMAB – A SINGLE CENTER EXPERIENCE. АММ [Internet]. 2023 Nov. 17 [cited 2026 Jul. 12];62(3). Available from: https://asistent.ceon.rs/index.php/amm/article/view/41552